Industries
Home / industries / health
Safe GenAI Testing and Digital Transformation for Health Organisations
Reduce the administrative burden on clinical teams, adopt GenAI responsibly, and protect patient privacy while enabling innovation across clinical, operational, and administrative systems.
Built for regulated healthcare environments where clinical data governance, patient privacy, and defensible AI testing are non-negotiable.
Healthcare organisations operate at the intersection of high-volume unstructured data, strict privacy obligations, and increasing pressure to adopt AI-enabled solutions. Clinical notes, correspondence, referrals, complaints, incident reports, and patient communications hold enormous value for operational efficiency and care outcomes but also represent significant privacy and compliance risk.
Key Challenges in Health
Sensitive patient and staff personal information embedded in free-text clinical and operational data
Strict regulatory and ethical obligations (privacy, consent, record handling)
Limited access to realistic data for AI testing and innovation
Manual, fragmented processes impacting care delivery and operational efficiency
Executive and board accountability for AI safety and data governance
Why Common Approaches to Test Data Fail
When health organisations recognise that real data cannot be used safely for GenAI testing, they typically turn to one of six workarounds. Each appears reasonable. Each fails for reasons that are worth understanding before they cost you a failed deployment.
The three data handling approaches, including redaction, masking, and anonymisation — all start with real data and attempt to make it safe. They differ in how much privacy risk they eliminate, but none of them produce test data that reflects how real health communications actually read under real-world conditions.
The three DIY alternatives; AI-generated data, manually created staff datasets, and scraped public data, avoid real data entirely but produce something that does not behave like it. AI systems evaluated against these datasets are not evaluated against the language patterns, edge cases, and contextual signals that matter most.
Every common approach either starts with real data and attempts to make it safe — or avoids real data and produces something that does not reflect reality. The result is AI systems that perform well in testing and fail in production.
Delivery Models
Data Infusion supports health organisations through two services: Client-Embedded Digital Solutions delivered within approved environments, and Unstructured Synthetic Data services that enable safe GenAI testing without exposure to real patient or staff data.
Client-Embedded Digital Solutions
Data Infusion designs, builds, and deploys, within approved health environments, using Microsoft 365 and the Power Platform.
​
These solutions focus on consolidating fragmented clinical and operational data, automating workflows, and strengthening governance while ensuring sensitive information remains within controlled systems.
Secure clinical and operational document management with metadata and access controls
Automated referral, incident, and request workflows
Governance-aligned reporting and dashboards for executive oversight
Collaboration platforms for multidisciplinary teams
Records management and compliance monitoring
Example Client-Embedded Use Cases
Client-Embedded Digital Solutions and Unstructured Synthetic Data services address different risks within healthcare organisations.
Together, they enable health providers to streamline clinical and operational workflows, strengthen governance, and safely design, test, and validate GenAI solutions without exposing real patient, clinician, or operational data.
Unstructured Synthetic Data Services
For unstructured synthetic data services, Data Infusion provides privacy-safe synthetic datasets for GenAI testing and validation. These datasets contain no real patient, clinician, or staff data and are designed to preserve language realism, context, and behavioural patterns.
​
This enables health organisations to test AI systems without breaching privacy, ethics, or regulatory obligations.
Testing clinical triage or classification agents
Validating AI-assisted document analysis and summarization
Simulating patient complaints or incident narratives for model evaluation
Stress-testing AI workflows for edge cases and rare scenarios
Ongoing monitoring of GenAI performance without real data exposure
Example Unstructured Synthetic Data Use Cases
These use cases are representative examples. Actual implementations are tailored to each organisation’s regulatory, operational, and risk context.
​
De-identification and masking of clinical records removes direct identifiers but cannot preserve the linguistic complexity of real patient correspondence — register variation, cultural language patterns, practitioner shorthand, and the informal tone of real clinical communication. AI systems tested on de-identified records are not tested against the full range of real-world clinical language.
What This Looks Like in Practice
A health organisation tested an AI clinical documentation review system using de-identified patient records assessed as compliant, only to find in deployment that the system struggled significantly with correspondence from non-native English speakers, a large proportion of the real patient population.
The deployment was paused, additional evaluation conducted, and the clinical governance gap formally documented and reported to the relevant health authorities, delaying planned efficiency outcomes.
Detailed Representative GenAI & Automation Use Cases in Health
Use Case 1
Patient Complaints and Incident Analysis (GenAI Testing)
Challenge
Healthcare organisations manage large volumes of unstructured patient complaints, incident reports, and adverse event narratives containing highly sensitive personal health information. Manual review of this correspondence is slow, inconsistent, and difficult to scale. AI systems designed to classify, prioritise, and route complaints and incidents must be tested against data that reflects the real range of patient communication — including informal language, cultural variation, and the emotional register of patients who are distressed, confused, or in pain. This data is subject to strict obligations under the Privacy Act 1988, applicable health records legislation, and clinical governance frameworks, and cannot be used safely for AI testing.
Why Redaction Fails
De-identification and redaction are the standard approaches for handling clinical records in AI development. They protect privacy by removing direct identifiers — patient names, dates of birth, and Medicare numbers. But a redacted clinical note, referral, or discharge summary no longer reads like real clinical correspondence. The practitioner shorthand, the cultural language patterns, the informal register of real patient communications — all of this is lost. AI systems tested on redacted health records are not tested against the linguistic complexity of real clinical data.
Synthetic Data Approach
Construct fully synthetic patient complaint and incident narrative datasets that replicate:
Clinical and safety signals embedded in unstructured correspondence with known escalation outcomes
Urgency and distress signals embedded in unstructured correspondence from citizens and students
Multi-cultural and multilingual language patterns reflecting real patient population diversity
Incident and adverse event narratives with embedded causality, urgency, and regulatory signals
Edge cases including vulnerable patients, complex clinical circumstances, and ambiguous reports
Executive Value
Reduce the cost of manual complaint review - validate AI classification before it handles real patient correspondence
Eliminate patient privacy and clinical governance risk from using real records in AI testing
Improve incident detection and escalation accuracy across the full range of patient communication styles
Defensible evidence of AI testing for clinical governance committees, health authorities, and board review
Use Case 2
Clinical Notes and Documentation Analysis (GenAI Testing)
Challenge
Clinical notes, discharge summaries, referral letters, and operational correspondence are rich sources of insight for AI-assisted documentation analysis and decision support. But they are unstructured, linguistically inconsistent, and contain sensitive personal health information that makes them unsafe to use directly for AI testing. AI systems designed to analyse, summarise, or extract intelligence from clinical documentation must be tested against data that reflects the real linguistic complexity of clinical practice — including practitioner shorthand, abbreviated language, and the informal register of real clinical correspondence.
Why Anonymisation Fails
Anonymisation aims to meet health privacy thresholds by transforming records, so individuals cannot be identified by any reasonably likely means. For unstructured clinical data — patient correspondence, complaint narratives, incident reports — this is extremely difficult to achieve reliably. Clinical context, treatment references, and demographic patterns can reintroduce identity even after direct identifiers are removed. Under the Privacy Act 1988 and applicable health records legislation, anonymisation is risk-managed, not risk-free. For health organisations where patient safety and clinical governance are paramount, that residual risk is unacceptable.
Synthetic Data Approach
Construct fully synthetic clinical documentation datasets that replicate:
Practitioner notes and correspondence across clinical specialities with realistic language and structure
Discharge summaries and referral letters with embedded clinical reasoning and decision trails
Abbreviated and shorthand clinical language patterns consistent with real practice environments
Multilingual and culturally diverse patient communication patterns
Edge cases including complex multi-condition presentations and ambiguous clinical scenarios
Executive Value
Reduce the administrative burden on clinical teams - validate documentation AI before it handles real records
Eliminate patient privacy and PHI exposure risk from using real clinical records in AI testing
Improve confidence in AI performance across the full linguistic range of clinical documentation
Defensible evidence of AI testing for clinical governance, health authority, and board-level review
Use Case 3
AI Triage and Care Navigation Testing (GenAI Testing)
Challenge
Healthcare providers are investing in AI to support clinical triage, care routing, and patient navigation. These systems must handle complex, edge-case scenarios that define the difference between appropriate and inappropriate care pathways. They must be tested against realistic patient communications that reflect the full range of how patients describe symptoms, express urgency, and navigate care systems including informal language, cultural variation, and the indirect communication patterns of patients who may not fully understand their own situation. Real patient data cannot be safely reused for this testing without significant privacy and clinical governance risk.
Why Masking Fail
Masking removes patient names and record identifiers but also strips the clinical nuance, causal language, and contextual signals that define how real health correspondence reads. A masked clinical note or patient complaint no longer reflects the linguistic diversity of real clinical communication; the abbreviated practitioner language, the non-native English patterns, the informal tone of real patient correspondence. AI systems tested on masked health data are not tested against the full range of real-world clinical language.
Synthetic Data Approach
Construct fully synthetic patient triage and care navigation datasets that replicate:
Patient symptom descriptions and care requests across urgency levels and clinical categories
Persona-driven variation in language, health literacy, cultural background, and communication style
Escalation and deterioration scenarios with embedded clinical urgency signals
Edge cases including rare presentations, multi-symptom complexity, and misdirected enquiries
Known triage outcomes to enable measurable validation of AI decision pathway accuracy
Executive Value
Reduce clinical and patient safety risk - validate triage AI before it makes real care routing decisions
Improve care navigation accuracy across the full linguistic and cultural range of your patient population
Eliminate exposure from using real citizen or student correspondence in AI testing
Eliminate patient privacy risk from using real clinical records in triage AI testing
Use Case 4
Ongoing AI Validation and Safety Monitoring (GenAI Testing)
Challenge
Once AI systems are deployed in clinical and operational health environments, organisations must continuously monitor for performance drift, emerging bias, and unintended behaviour. This ongoing validation requires repeatable, high-quality test datasets that can be used for baseline testing, regression testing, and safety monitoring over time. Production patient data cannot be safely reused for ongoing testing without triggering recurring privacy and consent obligations, and static test datasets quickly become unrepresentative as clinical practice and patient populations evolve.
Why Manually Created Datasets Fail
Some health organisations task clinical or administrative staff with manually writing synthetic patient scenarios, complaint narratives, or clinical notes for AI testing. The result is clean, grammatically correct, and clinically consistent; reflecting how healthcare professionals think patients write, not how patients actually communicate when distressed, confused, or describing symptoms informally. AI systems evaluated against manually created health data will struggle with the real linguistic diversity of patient populations in production.
Synthetic Data Approach
Construct repeatable synthetic validation datasets that enable:
Baseline and regression testing across consistent synthetic patient cohorts over time
Performance monitoring against evolving clinical language patterns and demographic variation
Safety monitoring for bias, drift, and edge-case failure across model updates
Documented audit trails of AI performance over time for clinical governance and regulatory review
Scalable dataset refresh without recurring privacy obligations or patient consent requirements
Executive Value
Maintain continuous AI safety assurance without recurring privacy risk from reusing patient data
Detect performance drift and emerging bias before it affects real patient care outcomes
Reduce the long-term compliance cost of AI monitoring across clinical and operational systems
Stronger governance posture for health authorities, clinical boards, and long-term regulatory review
These use cases are representative examples. Actual implementations are tailored to each organisation’s regulatory, operational, and risk context.
Next Steps
Industries